搜索
Evommune Inc
EVMN添加自选
22.920USD
+0.165+0.73%
收盘 05/15, 16:00（美东）报价延迟15分钟
825.54M总市值
亏损市盈率 TTM
关于 公司
Evommune Inc简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
Evommune Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
270.82K
-5.22%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-15.23%
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--
Dr. Jeegar P. Patel, Ph.D.
Dr. Jeegar P. Patel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Francois Beaubien, Ph.D.
Dr. Francois Beaubien, Ph.D.
Director
Director
--
--
Dr. David Eric Cohen, M.D.
Dr. David Eric Cohen, M.D.
Independent Director
Independent Director
--
--
Dr. Derek DiRocco, Ph.D.
Dr. Derek DiRocco, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
270.82K
-5.22%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-15.23%
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
EQT Partners AB
14.68%
EQT Life Sciences
13.69%
RA Capital Management, LP
9.70%
Pivotal Bioventure Partners Investment Advisor LLC
5.35%
Andera Partners S.A.S.
5.27%
其他
51.31%
持股股东
持股股东
占比
EQT Partners AB
14.68%
EQT Life Sciences
13.69%
RA Capital Management, LP
9.70%
Pivotal Bioventure Partners Investment Advisor LLC
5.35%
Andera Partners S.A.S.
5.27%
其他
51.31%
股东类型
持股股东
占比
Venture Capital
36.77%
Private Equity
19.95%
Investment Advisor
13.95%
Investment Advisor/Hedge Fund
12.52%
Hedge Fund
8.09%
Individual Investor
4.92%
Corporation
3.07%
Research Firm
0.18%
Bank and Trust
0.09%
其他
0.46%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
4
12.40M
0.00%
--
2026Q1
87
33.49M
92.97%
+17.08M
2025Q4
14
14.63M
46.41%
+14.63M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
EQT Partners AB
5.29M
14.68%
+358.68K
+7.28%
Feb 17, 2026
EQT Life Sciences
4.93M
13.69%
+4.93M
--
Nov 07, 2025
RA Capital Management, LP
3.49M
9.7%
+35.87K
+1.04%
Feb 17, 2026
Pivotal Bioventure Partners Investment Advisor LLC
1.93M
5.35%
--
--
Dec 31, 2025
Andera Partners S.A.S.
1.90M
5.27%
--
--
Dec 31, 2025
Nan Fung Life Sciences
1.44M
4%
--
--
Dec 31, 2025
RTW Investments L.P.
1.28M
3.56%
+1.28M
--
Dec 31, 2025
SymBiosis Capital Management, LLC
1.28M
3.56%
--
--
Dec 31, 2025
B Capital Group Management LP
1.10M
3.07%
+1.10M
--
Nov 06, 2025
JP Morgan Asset Management
1.10M
3.06%
+1.10M
--
Dec 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
